This paper was prepared by Mr Eshetu Wondemagegnehu, Department of Essential Drugs and Other Medicines. It builds on discussions and earlier work on how to strengthen drug regulation at the country level. Comments and contributions to the paper from the following people are gratefully acknowledged: Ms Kari Bremer, Ms Daphne Fresle, Dr Suzanne Hill, Mr Ishmail Joseph, Dr David Ofori-Adjei, Dr Jonathan D. Quick, Dr Sauwakon Ratanawijitrasin, Dr Valerio Reggi, and Ms Jacqueline Sawyer.
© World Health Organization 1999
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO). This document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.
The views expressed in documents by named authors are solely the responsibility of those authors.